A detailed history of Parkwood LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parkwood LLC holds 72,685 shares of AZN stock, worth $4.59 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
72,685
Previous 58,040 25.23%
Holding current value
$4.59 Million
Previous $4.53 Million 25.09%
% of portfolio
0.4%
Previous 0.56%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $1.12 Million - $1.28 Million
14,645 Added 25.23%
72,685 $5.66 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $1.63 Million - $1.98 Million
-24,467 Reduced 29.65%
58,040 $4.53 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $6.03 Million - $6.87 Million
-98,729 Reduced 54.48%
82,507 $5.59 Million
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $633,506 - $709,150
-10,236 Reduced 5.35%
181,236 $12.2 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $1.23 Million - $1.36 Million
18,983 Added 11.01%
191,472 $13 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $236,016 - $255,934
-3,376 Reduced 1.92%
172,489 $12.3 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $2.04 Million - $2.31 Million
32,326 Added 22.52%
175,865 $12.2 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $218,628 - $284,084
-4,033 Reduced 2.73%
143,539 $9.73 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $362,921 - $929,208
6,845 Added 4.86%
147,572 $8.09 Million
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $2.44 Million - $2.92 Million
-41,101 Reduced 22.6%
140,727 $141,000
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $186,494 - $224,650
3,347 Added 1.88%
181,828 $12.1 Million
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $5.62 Million - $6.64 Million
-104,010 Reduced 36.82%
178,481 $10.4 Million
Q3 2021

Nov 12, 2021

SELL
$55.56 - $60.79 $2.73 Million - $2.98 Million
-49,078 Reduced 14.8%
282,491 $17 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $3.05 Million - $3.79 Million
62,916 Added 23.42%
331,569 $19.9 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $1.07 Million - $1.23 Million
22,669 Added 9.22%
268,653 $13.4 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $10.4 Million - $12.4 Million
214,154 Added 672.81%
245,984 $12.3 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $9.39 Million - $10.8 Million
-176,863 Reduced 84.75%
31,830 $9.36 Million
Q2 2020

Aug 11, 2020

SELL
$43.1 - $55.31 $2.12 Million - $2.72 Million
-49,114 Reduced 19.05%
208,693 $11 Million
Q1 2020

May 12, 2020

SELL
$37.79 - $51.33 $496,447 - $674,322
-13,137 Reduced 4.85%
257,807 $11.5 Million
Q4 2019

Feb 10, 2020

SELL
$42.46 - $50.46 $1.81 Million - $2.15 Million
-42,706 Reduced 13.62%
270,944 $13.5 Million
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $6.87 Million - $7.79 Million
171,321 Added 120.37%
313,650 $14 Million
Q2 2019

Aug 08, 2019

SELL
$37.28 - $41.68 $99,574 - $111,327
-2,671 Reduced 1.84%
142,329 $5.88 Million
Q1 2019

May 06, 2019

BUY
$35.49 - $43.02 $5.15 Million - $6.24 Million
145,000 New
145,000 $5.86 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Parkwood LLC Portfolio

Follow Parkwood LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.